Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909895 · ClinicalTrials.gov registry record · NA
Study of the Effects of Negative Emotions on Endothelial Function
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT01909895 is a NA study that has completed, run by Columbia University. The registered enrollment target is 280 participants.
The verdict
NCT01909895, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
Study aims and hypotheses are as follows: Primary Hypotheses: Compared to the neutral condition, the anger recall task will acutely induce endothelial dysfunction by impairing endothelium-dependent arterial vasodilation (Hypothesis 1a); increasing circulating levels of EC-derived microparticles (EMPs), a marker of EC injury (Hypothesis 1b); and reducing circulating levels of bone marrow-derived endothelial progenitor cells (EPCs), a marker of EC reparative capacity (Hypothesis 1c). Secondary Hypotheses: Compared to the neutral condition, the depressed mood and separately the anxiety recall tasks will acutely impair endothelium-dependent arterial vasodilation, increase circulating levels of EMPs, and reduce circulating levels of bone marrow-derived EPCs. There will be a relation of the level of self-reported anger, depressed mood, and anxiety with endothelial dysfunction.
Interventions
- OTHER Anger Induction
- OTHER Depressed Mood Induction
- OTHER Anxiety Induction
- OTHER Neutral emotion task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2013-09-01 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909895
The ClinicalTrials.gov registry entry for NCT01909895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Anger Induction is the first listed.
NCT01909895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01909895 about?
NCT01909895 is a clinical study titled "Study of the Effects of Negative Emotions on Endothelial Function". Study aims and hypotheses are as follows: Primary Hypotheses: Compared to the neutral condition, the anger recall task will acutely induce endothelial dysfunction by impairing endothelium-dependent arterial vasodilation (Hypothesis 1a); increasing circulating levels of EC-derived microparticles (E...
What is the current status of trial NCT01909895?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2013-09-01. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT01909895?
The interventions under investigation include: Anger Induction (OTHER), Depressed Mood Induction (OTHER), Anxiety Induction (OTHER), Neutral emotion task (OTHER).
Who is sponsoring clinical trial NCT01909895?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.